Ifp Advisors, Inc Rhythm Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.3 - $30.85 $2,580 - $18,510	600 New	600 $20,000
Q3 2021 Oct 06, 2021	SELL	$11.68 - $20.72 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$18.52 - $22.55 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$20.25 - $39.49 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$21.17 - $32.61 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$18.13 - $30.61 $0 - $0	0 New	0 $0

190

67.1M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.18B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.